Poly(N-vinyl-pyrrolidone)-block-poly(Dx,L-lactide) as polymeric emulsifier for the preparation of biodegradable nanoparticles

Journal of Pharmaceutical Sciences

Volumn 96, Issue 7, 2007, Pages 1763-1775

  Gaucher, Geneviève ^a   Poreba, Monika ^a   Ravenelle, François ^b   Leroux, Jean Christophe ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Labopharm Inc   (Canada)

Author keywords

Controlled release; Emulsion; Freeze drying lyophilization; Hydrophobic drugs; Nanoparticles; Poly(lactic acid); Poly(N vinyl pyrrolidone) block poly(lactic acid); Polymeric drug carrier; Solubility parameters; Surfactant

Indexed keywords

ACETIC ACID ETHYL ESTER; COPOLYMER; DICHLOROMETHANE; EMULSIFYING AGENT; ETOPOSIDE; MACROGOL; MAGNESIUM CHLORIDE; NANOPARTICLE; PACLITAXEL; POLY(N VINYLPYRROLIDONE) BLOCK POLY(DEXTRO,LEVO LACTIDE); POLYETHYLENE GLYCOL BLOCK POLY(DEXTRO,LEVO LACTIDE); POLYLACTIDE; POVIDONE; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; EVAPORATION; FREEZE DRYING; IN VITRO STUDY;

EID: 34547208697     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20833     Document Type: Article

References (47)

1. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. 2005. Block copolymer micelles: Preparation, characterization and application in drug delivery. J Control Release 109:169-188.
2. Discher DE, Eisenberg A. 2002. Polymer vesicles. Science 297:967-973.
3. Bouchemal K, BrianÓon S, Perrier E, Fessi H. 2004. Nano-emulsion formulation using spontaneous emulsification: Solvent, oil and surfactant optimisation. Int J Pharm 280:241-251.
4. Cortesi R, Nastruzzi C. 1999. Liposomes, micelles and microemulsions as new delivery systems for cytotoxic alkaloids. PSTT 2:288-298.
5. Bulychev NA, Arutunov IA, Zubov VP, Verdonck B, Zhang T, Goethals EJ, Du Prez FE. 2004. Block copolymers of vinyl ethers as thermo-responsive colloidal stabilizers of organic pigments in aqueous media. Macromol Chem Phys 205:2457-2463.
6. Bouix M, Gouzi J, Charleux B, Vairon J-P, Guinot P. 1998. Synthesis of amphiphilic polyelectrolyte block copolymers using "livingradical polymerization. Application as stabilizers in emulsion polymerization. Macromol Rapid Commun 19:209-213.
7. Forster S, Antonietti M. 1998. Amphiphilic block copolymers in structure-controlled nanomaterial hybrids. Adv Mater 10:195-217.
8. Piirma I. 1992. Polymeric surfactants. New York: Marcel Dekker Inc.
9. Kabanov AV, Batrakov EV, Miller DW. 2003. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv Drug Deliv Rev 55:151-164.
10. ten Tije AJ, Verweij J, Loos WJ, Sparreboom A. 2003. Pharmacological effects of formulation vehicles. Clin Pharmacokinet 42:665-685.
11. Ratner BD, Horbett T, Hoffman AS, Hauschka DH. 1975. Cell adhesion to polymeric materials: Implications with respect to biocompatibility. J Biomed Mater Res 9:407-422.
12. Doebbler GF. 1966. Cryoprotective compounds. Cryobiology 3:2-11.
13. Deluca PP, Townsend MW. 1988. Use of lyoprotectants in the freeze-drying of a model protein, ribonuclease A. J Parent Sci Technol 42:190-199.
14. Luo L, Ranger M, Lessard DG, Le Garrec D, Gori S, Leroux JC, Rimmer S, Smith D. 2004. Novel amphiphilic diblock copolymer of low molecular weight poly(N-vinylpyrrolidone)-block-poly(D,L-lactide): Synthesis, characterization, and micellization. Macromolecules 37:4008-4013.
15. Le Garrec D, Gori S, Luo L, Lessard D, Smith DC, Yessine MA, Ranger M, Leroux JC. 2004. Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: In vitro and in vivo evaluation. J Control Release 99:83-101.
16. Le Garrec D, Gori S, Karkan D, Luo L, Lessard D, Smith D, Ranger M, Yessine MA, Leroux JC. 2005. Preparation, characterization, cytotoxicity and biodistribution of docetaxel-loaded polymeric micelle formulations. J Drug Deliv Sci Tech 15:115-120.
17. Hamaguchi T, Matsumura Y, Suzuki M, Goda R, Nakamura I, Nakatomi I, Yokoyama M, Kataoka K, Kakizoe T. 2005. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer 92:1240-1246.
18. Owens DE III, Peppas NA. 2005. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93-102.
19. Shah JC, Chen JR, Chow D. 1989. Preformulation study of etoposide: Identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide. Pharm Res 6:408-412.
20. Aso Y, Hayashi Y, Yoshioka S, Takeda Y, Kita Y, Nishimura Y, Arata Y. 1989. Epimerization and hydrolysis of etoposide analogues in aqueous solution. Chem Pharm Bull 37:422-424.
21. Krevelen DV. 1990. Cohesive properties and solubility. In: Krevelen DV, editor. Properties of polymers: Their correlation with chemical structure; their numerical estimation and prediction from additive group contributions. New York: Elsevier Scientific Pub. Co.
22. Grulke EA. 1989. Solubility Parameter Values. In: Brandrup J, Immergut EH, editors. Polymer handbook. New York: Wiley, pp 519-559.
23. Mo Y, Lim L-Y. 2005. Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Control Release 108:244-262.
24. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70:1-20.
25. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunck T, Muller RH. 2000. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influence of the corona (PEG chain length and surface density) and of the core composition on phagocytosis uptake and plasma protein adsorption. Colloid Surface B-Biointerface 18:301-313.
26. Lu W, Zhang Y, Tan Y-Z, Hu K-L, Jiang X-G, Fu S-K. 2005. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 107:428-448.
27. De Jaeghere F, Alléman E, Leroux JC, Stevels W, Feijen J, Doelker E, Gurny R. 1999. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: Influence on physical stability and in vitro cell uptake. Pharm Res 16:859-866.
28. Bouillot P, Babak V, Dellacherie E. 1999. Novel bioresorbable and bioeliminable surfactants for microsphere preparation. Pharm Res 16:148-154.
29. Chognot D, Six JL, Leonard M, Bonneaux F, Vigneron C, Dellacherie E. 2003. Physicochemical evaluation of PLA nanoparticles stabilized by water-soluble MPEO-PLA block copolymers. J Colloid Interface Sci 268.
30. Malzert A, Boury F, Saulnier P, Ivanova T, Panaiotov I, Benoit JP, Proust JE. 2003. Interfacial properties of adsorbed films made of a PEG2000 and PLA50 mixture or a copolymer at the dichloromethane-water interface. J Colloid Interface Sci 259:398-407.
31. Liu J, Xiao Y, Allen C. 2004. Polymer-drug compatibility: A guide to the development of delivery systems for the anticancer agent, Ellipticine. J Pharm Sci 93:132-143.
32. De Jaeghere F, Alléman E, Feijen J, Kissel T, Doelker E, Gurny R. 2000. Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEG) copolymer nanoparticles. Pharm Dev Technol 5:473-483.
33. 2001. Kollidon: Polyvinylpyrrolidone for the pharmaceutical industry. 6th edition, pp 108.
34. Lee JH, Lee HB, Andrade JD. 1995. Blood compatibility of polyethylene oxide surfaces. Prog Polym Sci 20:1043-1079.
35. D'Souza SS, DeLuca PP. 2006. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res 23:460-474.
36. Alléman E, Leroux JC, Gurny R, Doelker E. 1993. In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure. Pharm Res 10:1732-1737.
37. Galindo-Rodriguez S, Alleman E, Fessi H, Doelker E. 2004. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 21:1428-1439.
38. Beletsi A, Panagi Z, Avgoustakis K. 2005. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Int J Pharm 298:233-241.
39. Shakweh M, Besnard M, Nicolas V, Fattal E. 2005. Poly(lactide-co- glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. Eur J Pharm Biopharm 61:1-13.
40. Zhang Z, Feng SS. 2006. Nanoparticles for poly(-lactide)/vitamin E TPGS copolymer for cancer chemotherapy: Synthesis, formulation, characterization and in vitro drug release. Biomaterials 27: 262-270.
41. Dong Y, Feng S-S. 2006. Nanoparticles of poly(D,L-lactide)/ methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel. J Biomed Mater Res A. 78A:12-19.
42. Kishida A, Dressman JB, Yoshioka S, Aso Y, Takeda Y. 1990. Some determinants of morphology and release rate from poly(L)lactic acid microspheres. J Control Release 13:83-89.
43. Darwish IA, Florence AT, Saleh AM. 1989. Effects of hydrophobic agents on the solubility, precipitation and protein binding of etoposide. J Pharm Sci 78:577-581.
44. Mathew AE, Mejillano MR, Nath JP, Himes RH, Stella VJ. 1992. Synthesis and evaluation of some water-soluble prodrugs and derivatives of Taxol with antitumor activity. J Med Chem 35:145-151.
45. Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. 1993. Preparations of biodegradable nanopspheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and drug release behavior. J Controlled Release 25: 89-98.
46. Brendel M, Sandler S. 1999. The effect of salt and temperature on the infinite dilution activity coefficient of volatile organic chemicals in water. Fluid Phase Equilib 165:87-97.
47. Jeyanthi R, Thanoo BC, Mehta RC, DeLuca PP. 1996. Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. J Controlled Release 38:235-244.